Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT
Haris Ali1, Amandeep Salhotra1, Anthony S Stein1
1Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States.
Leukemia Research
|April 8, 2021
Abstract
No abstract available in PubMed .
More Related Videos
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
198
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.7K
